Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer-Reference-Cited by-同舟云学术

Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer

Published:2021-04 Issue: Volume:18 Page:5-10
ISSN:2405-6316
Container-title:Physics and Imaging in Radiation Oncology
language:en
Short-container-title:Physics and Imaging in Radiation Oncology

Author:

Jóhannesson Vilberg,Wieslander Elinore,Nilsson Per,Brun Eva,Bitzén Ulrika,Ahlgren Göran,Olsson Tomas,Bäck Sven,Kjellén Elisabeth,Gunnlaugsson Adalsteinn

Funder

Region Skåne

Mrs Berta Kamprad foundation for exploration and combat cancer

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Radiation

Reference31 articles.

1. Predictors of time to biochemical recurrence in a radical prostatectomy cohort within the PSA-era;Shahabi;Can Urol Assoc J,2016

2. Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery;Chang;Int J Urol,2015

3. The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions;Miyake;Prostate Int,2019

4. The dose-response of salvage radiotherapy following radical prostatectomy: A systematic review and meta-analysis;King;Radiother Oncol,2016

5. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy;Stephenson;J Clin Oncol,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer;Technical Innovations & Patient Support in Radiation Oncology;2024-03

2. A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy – The PROPER 1 trial;Clinical and Translational Radiation Oncology;2022-09